Randall D. Marshall
Hoofd Techniek/Wetenschap/O&O bij Eumentis Therapeutics, Inc.
Actieve functies van Randall D. Marshall
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Eumentis Therapeutics, Inc.
 Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation. | Directeur/Bestuurslid | - | - |
| Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Randall D. Marshall
Eerdere bekende functies van Randall D. Marshall
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 09-11-2011 | - |
Opleiding van Randall D. Marshall
| The Johns Hopkins University | Doctorate Degree |
| Rice University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Eumentis Therapeutics, Inc.
Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Randall D. Marshall
- Ervaring
